HIV Citation List: January 17 - January 30, 2014

PubMed citations

1. Bicyclic 1-Hydroxy-2-oxo-1,2-dihydropyridine-3-carboxamide-containing HIV-1 Integrase Inhibitors Having High Antiviral Potency against Cells Harboring Raltegravir-resistant Integrase Mutants. Zhao, X.Z., S.J. Smith, M. Metifiot, B.C. Johnson, C. Marchand, Y. Pommier, S.H. Hughes, and T.R. Burke. Journal of Medicinal Chemistry, 2014. [Epub ahead of print]. PMID[24471816].

[PubMed]. HIV_0117-013014.

2. Development of a Vaginal Delivery Film Containing EFdA, a Novel anti-HIV Nucleoside Reverse Transcriptase Inhibitor. Zhang, W., M.A. Parniak, S.G. Sarafianos, M.R. Cost, and L.C. Rohan. International Journal of Pharmaceutics, 2014. 461(1-2): p. 203-213. PMID[24333452].

[PubMed]. HIV_0117-013014.

3. Rational Design of Substrate-based Multivalent Inhibitors of the Histone Acetyltransferase Tip60. Yang, C., L. Ngo, and Y.G. Zheng. ChemMedChem, 2014. [Epub ahead of print]. PMID[24446345].

[PubMed]. HIV_0117-013014

4. Passive Immunization of Macaques with Polyclonal anti-SHIV IgG against a Heterologous Tier 2 SHIV: Outcome Depends on IgG Dose. Sholukh, A.M., S.N. Byrareddy, V. Shanmuganathan, G. Hemashettar, S.K. Lakhashe, R.A. Rasmussen, J.D. Watkins, H.K. Vyas, S. Thorat, T. Brandstoetter, M.M. Mukhtar, J.K. Yoon, F.J. Novembre, F. Villinger, G. Landucci, D.N. Forthal, S. Ratcliffe, I. Tuero, M. Robert-Guroff, V.R. Polonis, M. Bilska, D.C. Montefiori, W.E. Johnson, H.C. Ertl, and R.M. Ruprecht. Retrovirology, 2014. 11(1): p. 8. PMID[24444350].

[PubMed]. HIV_0117-013014

5. Inhibition of HIV by Legalon-SIL Is Independent of Its Effect on Cellular Metabolism.McClure, J., D.H. Margineantu, I.R. Sweet, and S.J. Polyak. Virology, 2014. 449: p. 96-103. PMID[24418542].

[PubMed]. HIV_0117-013014

6. Toll-like Receptor Agonists Are Potent Inhibitors of Human Immunodeficiency Virus-type 1 Replication in Peripheral Blood Mononuclear Cells.Buitendijk, M., S.K. Eszterhas, and A.L. Howell. AIDS Research and Human Retroviruses, 2014. [Epub ahead of print]. PMID[24328502].

[PubMed]. HIV_0117-013014

ISI Web of Knowledge Citations

7. Design, Synthesis and Preliminary SAR Studies of Novel N-Arylmethyl Substituted Piperidine-linked Aniline Derivatives as Potent HIV-1 NNRTIs.Zhang, L.Z., P. Zhan, X.W. Chen, Z.Y. Li, Z.M. Xie, T. Zhao, H.Q. Liu, E. De Clercq, C. Pannecouque, J. Balzarini, and X.Y. Liu. Bioorganic & Medicinal Chemistry, 2014. 22(1): p. 633-642. ISI[000329068400060].

[WOS]. HIV_0117-013014.

8. Dual-acting Stapled Peptides Target Both HIV-1 Entry and Assembly.Zhang, H.T., F. Curreli, A.A. Waheed, P.Y. Mercredi, M. Mehta, P. Bhargava, D. Scacalossi, X.H. Tong, S. Lee, A. Cooper, M.F. Summers, E.O. Freed, and A.K. Debnath. Retrovirology, 2013. 10. ISI[000329046300001].

[WOS]. HIV_0117-013014.

9. New Insights into Inhibition of Human Immunodeficiency Virus Type 1 Replication through Mutant tRNA(Lys3). Wu, C.X., V.R. Nerurkar, and Y.N. Lu. Retrovirology, 2013. 10. ISI[000329043500004].

[WOS]. HIV_0117-013014.

10. Protease Inhibitors Effectively Block Cell-to-Cell Spread of HIV-1 between T Cells. Titanji, B.K., M. Aasa-Chapman, D. Pillay, and C. Jolly. Retrovirology, 2013. 10. ISI[000329050400001].

[WOS]. HIV_0117-013014.

11. Stereoselective Synthesis of (Z)-1-Benzhydryl-4-cinnamylpiperazines via the Wittig Reaction. Shivprakash, S. and G.C. Reddy. Synthetic Communications, 2014. 44(5): p. 600-609. ISI[000328930400003].

[WOS]. HIV_0117-013014.

12. Design, Synthesis and Activity Evaluation of Novel Bivalent HIV-1 Fusion Inhibitor. Ling, Y.B., K. Wang, X.F. Jiang, L.F. Cai, and K.L. Liu. Chemical Journal of Chinese Universities, 2013. 34(9): p. 2102-2107. ISI[000328926400014].

[WOS]. HIV_0117-013014.

13. Synthesis of Novel 4'-C-Methyl-1',3'-dioxolane Pyrimidine Nucleosides and Evaluation of Its anti-HIV-1 Activity. Kubota, Y., Y. Kaneda, K. Haraguchi, M. Mizuno, H. Abe, S. Shuto, T. Hamasaki, M. Baba, and H. Tanaka. Tetrahedron, 2013. 69(51): p. 10884-10892. ISI[000328808300013].

[WOS]. HIV_0117-013014.

14. Interactions of Peptide Triazole thiols with Env gp120 Induce Irreversible Breakdown and Inactivation of Hiv-1 Virions. Bastian, A.R., M. Contarino, L.D. Bailey, R. Aneja, D.R.M. Moreira, K. Freedman, K. McFadden, C. Duffy, A. Emileh, G. Leslie, J.M. Jacobson, J.A. Hoxie, and I. Chaiken. Retrovirology, 2013. 10. ISI[000329050300001].

[WOS]. HIV_0117-013014.

15. Copper-catalyzed Domino Synthesis of 4-Oxopyrimido[1,2-a]indole Derivatives. Wang, Y.Y., R.J. Wang, Y.Y. Jiang, C.Y. Tan, and H. Fu. Advanced Synthesis & Catalysis, 2013. 355(14-15): p. 2928-2935. ISI[000328149300026].

[WOS]. HIV_0117-013014.

16. Unique Characteristics of Histone Deacetylase Inhibitors in Reactivation of Latent HIV-1 in Bcl-2-transduced Primary Resting CD4+ T Cells.Shan, L., S.F. Xing, H.C. Yang, H. Zhang, J.B. Margolick, and R.F. Siliciano. Journal of Antimicrobial Chemotherapy, 2014. 69(1): p. 28-33. ISI[000328425400004].

[WOS]. HIV_0117-013014.

17. Synthesis and anti-HIV-1 Activity of 1- omega-(Phenoxy)alkyl and -alkenyl uracil Derivatives. Paramonova, M.P., D.A. Babkov, V.T. Valuev-Elliston, A.V. Ivanov, S.N. Kochetkov, C. Pannecouque, A.A. Ozerov, J. Balzarini, and M.S. Novikov. Pharmaceutical Chemistry Journal, 2013. 47(9): p. 459-463. ISI[000328839300002].

[WOS]. HIV_0117-013014.

18. GANP Interacts with APOBEC3G and Facilitates Its Encapsidation into the Virions to Reduce HIV-1 Infectivity. Maeda, K., S.A. Almofty, S.K. Singh, M.M.A. Eid, M. Shimoda, T. Ikeda, A. Koito, P. Pham, M.F. Goodman, and N. Sakaguchi. Journal of Immunology, 2013. 191(12): p. 6030-6039. ISI[000328483900030].

[WOS]. HIV_0117-013014.

19. F(ab')(2) Fragment of a gp41 NHR-trimer-induced IgM Monoclonal Antibody Neutralizes HIV-1 Infection and Blocks Viral Fusion by Targeting the Conserved gp41 Pocket. Lu, L., M.L. Wei, Y.X. Chen, W.L. Xiong, F. Yu, Z. Qi, S.B. Jiang, and C.E. Pan. Microbes and Infection, 2013. 15(13): p. 887-894. ISI[000328526200006].

[WOS]. HIV_0117-013014.

20. Design, Synthesis, and Antiviral Evaluation of Chimeric Inhibitors of HIV Reverse Transcriptase. Iyidogan, P., T.J. Sullivan, M.D. Chordia, K.M. Frey, and K.S. Anderson. ACS medicinal chemistry letters, 2013. 4(12): p. 1183-1188. ISI[000328529400015].

[WOS]. HIV_0117-013014.

21. Novel Bioactive Dibenzocyclooctadiene Lignans from Schisandra neglecta.Gao, X.M., D.Y. Niu, C.Y. Meng, F.Q. Yao, B. Zhou, R.R. Wang, L.M. Yang, Y.T. Zheng, Q.F. Hu, H.D. Sun, and W.L. Xiao. Journal of the Brazilian Chemical Society, 2013. 24(12): p. 2021-+. ISI[000328703200017].

[WOS]. HIV_0117-013014.

22. Hydrazones and 1,3-Thiazolidin-4-ones Incorporating Furman Moiety Synthesized from Eugenol, the Main Constituent of Ocimum santum L. Oil. Dinh, N.H., T.T. Huan, H.T.T. Lan, and S.B. Han. Heterocycles, 2013. 87(11): p. 2319-2332. ISI[000328519000007].

[WOS]. HIV_0117-013014.